This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time.
Will there or won’t there be a federal moratorium on state-level regulation of AI?That’s only one question healthcare stakeholders are asking as 2025’s time begins running out.
Advanced AI technologies are starting to play a bigger role in TAVR care, helping cardiologists plan ahead, make critical decisions and predict potential complications. Looking to the future, though, it is clear this is just the beginning.
Hospitals could be turning away high-risk heart patients to help their TAVR programs receive a higher ranking, according to new research published in JACC: Cardiovascular Interventions.
Regardless of effectiveness or lack thereof, pandemic-response measures like masking and social distancing give many people a sense of being better off with them than without them.
Generative AI of the “large language” kind has been an attention hog over the past 10 or 11 months. The buzz has been so loud and constant that it’s all but asking to be dismissed as hype.
“Many within the healthcare industry believe that cardiovascular care will be increasingly delivered in non-traditional ambulatory settings,” according to one author. “The cardiovascular care community must consider and prepare for this eventuality."
Do you know who owns your personal favorite doctor’s practice? Could it be a healthcare conglomerate? An insurance company? A private equity firm? Amazon?